Related Experiment Video
Updated: Mar 18, 2026

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
Effect of Erythromycin on Gastric Emptying Time of Low Birth Weight Babies
S S Mathai1, K S Bawa2, A Bhandari3
1Associate Professor (Paediatrics), Armed Forces Medical College, Pune-411040.
Insights
Low dose erythromycin safely reduced gastric emptying time in preterm neonates. This intervention was effective in babies born after 34 weeks of gestation, with no observed side effects.
Area of Science:
- Neonatal Medicine
- Pharmacology
- Gastroenterology
Background:
- Investigating the impact of low-dose erythromycin on gastric emptying in low birth weight (LBW) neonates.
- Assessing effects in neonates receiving breast milk, supplements, or human milk fortifier (HMF).
Purpose of the Study:
- To evaluate the promotility effects of low-dose erythromycin on gastric emptying time (GET) in LBW neonates.
- To determine safety and efficacy in different feeding regimens.
Main Methods:
- Randomized control trial with 50 neonates receiving oral erythromycin (6mg/kg/day) or placebo for four days.
- Gastric emptying time (GET) assessed via ultrasonography measuring antral cross-sectional area (ACSA).
- Side effects and feeding type (breast milk, supplements, HMF) were monitored.
Main Results:
- Erythromycin significantly decreased GET in the test group, particularly in preterm infants born after 34 weeks gestation.
- The reduction in GET was observed with breast milk alone and with supplements, but not with HMF.
- No adverse side effects were reported during the intervention.
Conclusions:
- Low-dose erythromycin is a safe and effective method for reducing gastric emptying in preterm neonates.
- The benefits were most pronounced in infants born after 34 weeks gestation within the first two weeks of life.
Background:
To study the promotility effects of low dose erythromycin on gastric emptying time in a population of normal low birth weight (LBW) neonates on breast feeds with or without nutritional supplements and human milk fortifier (HMF).
Method:
A randomised control trial involving 50 neonates was undertaken and they were given 6mg/kg/day of oral erythromycin or placebo in three divided doses for four consecutive days in the first two weeks of life. The gastric emptying time (GET) was assessed ultrasonographically by measuring the decrease in the antral cross sectional area (ACSA). The time taken for the ACSA to become half the prefeed value, was taken as t/2 or half GET. The babies were also assessed for pre and post intervention side effects of the drug. The results were analysed using SPSS ver 11.5.
Results:
The test group showed a significant decrease in GET after the intervention. This effect was mainly seen in the preterm babies as compared to term Small for Gestational Age (SGA) babies. The decrease in GET was more in babies born after 34 weeks of gestation as compared to smaller babies. The reduction in GET was seen in babies on breast milk alone and nutritional supplements with breast milk but not when HMF was added. No side effects of the drug were noted.
Conclusion:
Low dose erythromycin is a safe way of decreasing gastric emptying in preterm babies born after 34 weeks of gestation in the first two weeks of life.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Gastric Emptying
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Drug Absorption: Factors Affecting GI Absorption
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

